UroGen Pharma Ltd a clinicalstage biopharmaceutical company developing treatments to address unmet needs in the field of urooncology today announced that it has entered into an agreement with Janssen Research Development LLC Janssen to conduct an earlystage feasibility evaluation in a therapeutic a...
Eli Lilly and Company and Avidity Biosciences Inc today announced a global licensing and research collaboration focused on the discovery development and commercialization of potential new medicines in immunology and other select indications
Elpiscience BioPharma and BioTechne Corporation announced today that the companies have entered into a strategic collaboration for the development of anticancer therapeutics
Oakrum Pharma LLC Oakrum announced today that it has entered into an agreement with Biophore India Pharmaceuticals Pvt Ltd Biophore to develop and manufacture two prescription generic pharmaceutical products that are intended to be commercialized in the US under the Oakrum label
Nonprofit drug developer TB Alliance and pharmaceutical company Mylan NV NASDAQ MYL today announced a global collaboration to make the experimental drug pretomanid accessible for use in two investigational drug regimens for pulmonary tuberculosis TB TB a bacterial infection transmitted through the a...
Velabs Therapeutics specializing in the fast generation of functional therapeutic antibodies today announced that it has entered into an agreement with Chiome Bioscience Inc Tokyo to jointly discover modulatory and functional antibodies for one of Chiomes GPCR target genes
Macrogen a precision medicine and biotechnology company is on April th on Exosome Plus P John Wook announced a contract for exclusive supply of exosome isolation kit and announced on April that it has signed a business agreement on joint development of an exosomebased diagnostic and therapeutic age...
EpimAb Biotherapeutics an emerging biopharmaceutical company based in Shanghai announced today that the United States Patent and Trademark Office USPTO has granted the US Patent No entitled FabsInTandem Immunoglobulin and Uses Thereof Based on EpimAbs globally filed first application this patent br...
Vineti Inc the leading software platform of record for personalized therapeutics today announced a new partnership to advance and scale Marker Therapeutics T cell therapy pipeline
Tonix Pharmaceuticals Holding Corp a clinicalstage biopharmaceutical company developing pharmaceutical products to treat psychiatric and pain conditions and biological products to improve biodefense
Hilton Boston Logan Airport
Conference Series LLC Ltd
Conference Series LLC Ltd
Radisson Hotel Narita
Amsterdam Marriott Hotel
Staff Engineer, Manufacturing Science and Technology, South East AsiaKaren Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...
Introduction The Human Immune deficiency Virus HIV infected brain cells through virus or HIV linked oncogenes The major complication of such infection leads to dementia peripheral neuropathies neurosyphilis meningitis etc The development of neuroAIDS still remains a topic of debate due to multifaceted symptom complicated pathology alon
Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to in
Abstract Background Slow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime
PhaseBio Pharmaceuticals is planning to announce PB a novel reversal agent for the Antiplatelet drug Ticagrelor PB is a novel recombinant human monoclonal antibody antigenbinding fragment or Fab fragment designed to reverse the Antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations
Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward
In ethically promoting Pharma business field force are the resources who generate prescriptions for the products being promoted thus bring in revenue...
Soft gels also known as soft capsules or soft caps are a highly popular pharmaceutical and nutraceutical dosage form with around units consumed every...
What are the major changes you see affecting todays pharmaceutical supply chain The primary change we see is that of market dynamics and rapid...